(Q46023904)

18 December 2017

title

Treatment of genital warts with an immune-response modifier (imiquimod). (English)

1 reference

18 December 2017

author name string

K R Beutner

1

1 reference

18 December 2017

S L Spruance

2

1 reference

18 December 2017

A J Hougham

3

1 reference

18 December 2017

T L Fox

4

1 reference

18 December 2017

M L Owens

5

1 reference

18 December 2017

J M Douglas

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

18 December 2017

Journal of the American Academy of Dermatology

published in

1 reference

18 December 2017

volume

38

1 reference

18 December 2017

issue

2 Pt 1

1 reference

18 December 2017

page(s)

230-239

1 reference

18 December 2017

Epidemiology of genital human papillomavirus infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Interferon therapy for condylomata acuminata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Natural interferon alfa for treatment of condylomata acuminata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Patient-applied podofilox for treatment of genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Cytokine induction in mice by the immunomodulator imiquimod.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Efficacy of S26308 against guinea pig cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Cryotherapy and CO2-laser vaporization in the treatment of cervical and vaginal human papillomavirus (HPV) infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Cryotherapy in the treatment of condylomata acuminata: a controlled study of 64 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Carbon dioxide laser treatment of external genital lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Laser treatment of recurrent urethral condylomata acuminata in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970243-9

7 January 2021

10.1016/S0190-9622(98)70243-9

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

9486679

1 reference

18 December 2017